Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells

Bor-Chyuan Su,Guan-Yu Chen,Chun-Ming Yang,Wei-Ting Chuang,Meng-Chieh Lin,Pei-Ling Hsu,Chu-Wan Lee,Chih-Cheng Cheng,Shih-Ying Wu,Bo-Syong Pan,Hsin-Hsien Yu,Bor-Chyuan SuGuan-Yu ChenChun-Ming YangWei-Ting ChuangMeng-Chieh LinPei-Ling HsuChu-Wan LeeChih-Cheng ChengShih-Ying WuBo-Syong PanHsin-Hsien Yua Department of Anatomy and Cell Biology,School of Medicine,College of Medicine,Taipei Medical University,Taipei,Taiwanb Graduate Institute of Medical Sciences,College of Medicine,Taipei Medical University,Taipei,Taiwanc TMU Research Center of Cancer Translational Medicine,Taipei Medical University,Taipei,Taiwand School of Medical Laboratory Science and Biotechnology,College of Medical Science and Technology,Taipei Medical University,Taipei,Taiwane Department of Anatomy,School of Medicine,College of Medicine,Kaohsiung Medical University,Kaohsiung,Taiwanf Department of Medical Research,Kaohsiung Medical University Hospital,Kaohsiung,Taiwang Department of Nursing,National Tainan Junior College of Nursing,Tainan,Taiwanh Division of General Surgery,Department of Surgery,Wan Fang Hospital,Taipei Medical University,Taipei,Taiwani Department of Cancer Biology,Wake Forest Baptist Medical Center,Wake Forest University,Winston-Salem,NC,USAj Department of Pathology,Duke University School of Medicine,Durham,NC,USAk Division of General Surgery,Department of Surgery,School of Medicine,College of Medicine,Taipei Medical University,Taipei,Taiwan

DOI: https://doi.org/10.1080/02656736.2024.2310017

2024-02-15

International Journal of Hyperthermia

Abstract:Objective: Gastric cancer with peritoneal metastasis is considered to be final stage gastric cancer. One current treatment approach for this condition is combined cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). However, the therapeutic mechanisms of HIPEC remain largely undescribed. Method: In order to assess the cellular effects of HIPEC in vitro , we treated AGS human gastric adenocarcinoma cells with or without 5-fluorouracil (5-Fu) at 37 °C or at 43 °C (hyperthermic temperature) for 1 h followed by incubation at 37 °C for 23 h. The impacts of hyperthermia/5-Fu on apoptosis, cell survival signals, oxidative stress, chemoresistance-related proteins and programmed death-ligand 1 (PD-L1) expression were measured. Results: Our results showed that hyperthermia potentiates 5-Fu-mediated cytotoxicity in AGS cells. Furthermore, the combination of 5-Fu and hyperthermia reduces levels of both phosphorylated STAT3 and STAT3, while increasing the levels of phosphorylated Akt and ERK. In addition, 5-Fu/hyperthermia enhances reactive oxygen species and suppresses superoxide dismutase 1. Chemoresistance-related proteins, such as multidrug resistance 1 and thymidylate synthase, are also suppressed by 5-Fu/hyperthermia. Interestingly, hyperthermia enhances 5-Fu-mediated induction of glycosylated PD-L1, but 5-Fu-mediated upregulation of PD-L1 surface expression is prevented by hyperthermia. Conclusion: Taken together, our findings provide insights that may aid in the development of novel therapeutic strategies and enhanced therapeutic efficacy of HIPEC.

oncology,radiology, nuclear medicine & medical imaging